Table 3

Observed and estimated HbA1c concentrations during the study period

Baseline6 months12 monthsDifference (12 months)
All patients
 Observed62 (55 to 72)58 (52 to 65)58 (52 to 66)
 Number1362790687
 Estimated64.1 (62.5 to 64.9)59.2 (58.4 to 60.2) **60.1 (59.2 to 61.1) **−4.0 (–5.5 to –2.6)
T1DM
 Observed62 (54 to 71)57 (51 to 65)58 (53 to 66)
 Number1051628543
 Estimated63.5 (62.7 to 64.3)59.2 (58.2 to 60.1) **60.2 (59.1 to 61.3) **−3.3 (–4.9 to –1.7)
T2DM
 Observed67 (56 to 78)61 (53 to 67)62 (53 to 69)
 Number22311499
 Estimated68.2 (66.3 to 70.8)61.2 (58.6 to 63.8) **62.0 (59.2 to 64.7) *−6.2 (–10.3 to –2.1)
Other forms of DM
 Observed61 (51 to 71)57 (51 to 63)55 (50 to 62)
 Number884845
 Estimated62.2 (59.6 to 64.8)56.1 (52.6 to 59.6)*56.2 (52.6 to 59.8) *−6.0 (–11.5 to –0.6)
  • Values are presented as numbers, medians (25th, 75th centiles) and estimated means (difference) (95% CI). Data are presented as observed data and estimated data using the linear mixed model. HbA1c concentrations are presented in mmol/mol.

  • *p<0.05 as compared with baseline; **p<0.001 as compared with baseline.

  • DM, diabetes mellitus; T1DM, type I diabetes mellitus; T2DM, type II diabetes mellitus.